A detailed history of Macquarie Group LTD transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 258,855 shares of ZBH stock, worth $28 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
258,855
Previous 241,201 7.32%
Holding current value
$28 Million
Previous $31.8 Million 11.75%
% of portfolio
0.03%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$106.25 - $130.01 $1.88 Million - $2.3 Million
17,654 Added 7.32%
258,855 $28.1 Million
Q1 2024

May 14, 2024

SELL
$119.98 - $132.61 $28,795 - $31,826
-240 Reduced 0.1%
241,201 $31.8 Million
Q4 2023

Feb 14, 2024

BUY
$102.72 - $121.7 $382,529 - $453,210
3,724 Added 1.57%
241,441 $29.4 Million
Q3 2023

Nov 14, 2023

SELL
$110.76 - $143.18 $282,659 - $365,395
-2,552 Reduced 1.06%
237,717 $26.7 Million
Q2 2023

Aug 14, 2023

SELL
$126.43 - $145.6 $161,451 - $185,931
-1,277 Reduced 0.53%
240,269 $35 Million
Q1 2023

May 15, 2023

SELL
$121.91 - $130.94 $33.2 Million - $35.6 Million
-272,159 Reduced 52.98%
241,546 $31.2 Million
Q4 2022

Feb 21, 2023

SELL
$104.7 - $128.4 $1.42 Million - $1.74 Million
-13,559 Reduced 2.57%
513,705 $65.5 Million
Q3 2022

Nov 14, 2022

SELL
$101.65 - $119.27 $2.62 Million - $3.07 Million
-25,733 Reduced 4.65%
527,264 $55.1 Million
Q2 2022

Aug 15, 2022

BUY
$102.23 - $133.85 $1.14 Million - $1.5 Million
11,175 Added 2.06%
552,997 $58.1 Million
Q1 2022

May 16, 2022

BUY
$108.42 - $129.58 $10.1 Million - $12.1 Million
93,266 Added 20.79%
541,822 $69.3 Million
Q4 2021

Feb 11, 2022

SELL
$115.43 - $146.63 $181 Million - $229 Million
-1,564,211 Reduced 77.71%
448,556 $57 Million
Q3 2021

Nov 12, 2021

BUY
$136.35 - $158.76 $1.76 Million - $2.05 Million
12,932 Added 0.65%
2,012,767 $295 Million
Q2 2021

Aug 13, 2021

BUY
$152.95 - $173.41 $270 Million - $306 Million
1,765,746 Added 754.31%
1,999,835 $322 Million
Q1 2021

May 14, 2021

SELL
$148.16 - $159.71 $859,328 - $926,318
-5,800 Reduced 2.42%
234,089 $37.5 Million
Q4 2020

Feb 16, 2021

SELL
$128.25 - $151.41 $1.63 Million - $1.92 Million
-12,700 Reduced 5.03%
239,889 $37 Million
Q3 2020

Nov 13, 2020

SELL
$113.59 - $141.68 $1.25 Million - $1.56 Million
-10,979 Reduced 4.17%
252,589 $34.4 Million
Q2 2020

Aug 11, 2020

SELL
$87.02 - $133.4 $294,301 - $451,158
-3,382 Reduced 1.27%
263,568 $31.5 Million
Q1 2020

May 15, 2020

SELL
$78.28 - $155.73 $2.24 Million - $4.45 Million
-28,600 Reduced 9.68%
266,950 $27 Million
Q4 2019

Feb 14, 2020

BUY
$127.4 - $146.83 $17.1 Million - $19.7 Million
134,500 Added 83.51%
295,550 $44.2 Million
Q3 2019

Nov 14, 2019

SELL
$113.33 - $138.46 $1.06 Million - $1.29 Million
-9,350 Reduced 5.49%
161,050 $22.1 Million
Q2 2019

Nov 06, 2019

BUY
$108.87 - $125.09 $18.2 Million - $20.9 Million
166,800 Added 4633.33%
170,400 $20.1 Million
Q2 2019

Aug 14, 2019

SELL
$108.87 - $125.09 $19.2 Million - $22.1 Million
-176,750 Reduced 98.0%
3,600 $424,000
Q1 2019

May 15, 2019

SELL
$97.5 - $125.79 $4.68 Million - $6.04 Million
-48,000 Reduced 21.02%
180,350 $23 Million
Q4 2018

Feb 15, 2019

BUY
$94.4 - $126.76 $89,680 - $120,422
950 Added 0.42%
228,350 $23.7 Million
Q3 2018

Nov 15, 2018

BUY
$108.41 - $127.64 $70,466 - $82,966
650 Added 0.29%
227,400 $29.9 Million
Q2 2018

Aug 14, 2018

BUY
$102.12 - $114.04 $1.14 Million - $1.28 Million
11,200 Added 5.2%
226,750 $25.3 Million
Q1 2018

May 11, 2018

BUY
$104.31 - $124.46 $10.3 Million - $12.3 Million
99,100 Added 85.1%
215,550 $23.5 Million
Q4 2017

Feb 15, 2018

SELL
$105.55 - $120.83 $42,220 - $48,332
-400 Reduced 0.34%
116,450 $14.4 Million
Q3 2017

Nov 08, 2017

BUY
$106.92 - $117.79 $12.5 Million - $13.8 Million
116,850
116,850 $13.7 Million

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $22.7B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.